In Business Environment Ratings for Q310, the UK has maintained its fifth place out of the ten Western European markets surveyed. The ratings criteria serve to reinforce our estimation of the country's potential due to a stronger emphasis on the regulatory environment, which we see as a major factor affecting the business environment for drugmakers. |
|
Read more...
|